Renal elimination of amikacin and the aging process

被引:14
作者
Ducher, M
Maire, P
Cerutti, C
Bourhis, Y
Foltz, F
Sorensen, P
Jelliffe, R
Fauvel, JP
机构
[1] Hop A Charial, ADCAPT, Francheville, France
[2] Univ Lyon 1, Equipe Accueil 645, F-69365 Lyon, France
[3] Univ So Calif, Keck Sch Med, Lab Appl Pharmacokinet, Los Angeles, CA USA
关键词
D O I
10.2165/00003088-200140120-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Although amikacin is primarily eliminated via glomerular filtration, drug concentrations are not consistently predicted in all patients. To better describe the relationship between amikacin clearance and both age and renal function, we used a new heuristic approach involving statistical analysis of dependence. Design and setting: Retrospective pharmacokinetic study using data from seven centres in France. Participants: 634 patients with sepsis aged between 18 and 98 years of age who received intravenous amikacin. Methods: Clearance of amikacin was modelled using the NonParametric EM algorithm for a two-compartment model (NPEM2) with intravenous infusion. Results: A total of 2499 serum amikacin determinations was available for analysis. The relationship between the clearance of amikacin and age was weak. Interestingly, the Z method, which filters data based on dependence criteria, selected data that were best fitted by a polynomial function (r = 0.90; p < 0.001). This representation of the polynomial function was similar to a previously proposed theoretical model describing covariations between the clearance of amikacin and age. However, the polynomial function applied! to only 33% of the patients that were selected by the Z method. The correlation between the clearance of amikacin and renal function was also relatively low (r = 0.39). The Z method exhibited a continuous and strong dependence pattern between the clearance of amikacin and age for 49% of the patients. Conclusions: The Z methodology, which filters data using dependence criteria, confirms that age, renal function and amikacin clearance are strongly related, but only in less than half of a large sample of patients with sepsis without renal pathology. These results suggest that other variables should be taken into account in order to improve the description of the behaviour of amikacin. The Z methodology improved the classical description of relationships between variables, and should be applied to better select pertinent variables in pharmacokinetic studies.
引用
收藏
页码:947 / 953
页数:7
相关论文
共 23 条
[1]   NOMOGRAM FOR ESTIMATING CREATININE CLEARANCE [J].
BJORNSSON, TD ;
COCCHETTO, DM ;
MCGOWAN, FX ;
VERGHESE, CP ;
SEDOR, F .
CLINICAL PHARMACOKINETICS, 1983, 8 (04) :365-369
[2]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[3]   POPULATION PHARMACOKINETICS OF AMIKACIN IN INTENSIVE-CARE UNIT PATIENTS STUDIED BY NPEM ALGORITHM [J].
DEBORD, J ;
PESSIS, C ;
VOULTOURY, JC ;
MARQUET, P ;
LOTFI, H ;
MERLE, L ;
LACHSATRE, G .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (01) :57-61
[4]   A NEW NONINVASIVE STATISTICAL-METHOD TO ASSESS THE SPONTANEOUS CARDIAC BAROREFLEX IN HUMANS [J].
DUCHER, M ;
FAUVEL, JP ;
GUSTIN, MP ;
CERUTTI, C ;
NAJEM, R ;
CUISINAUD, G ;
LAVILLE, M ;
POZET, N ;
PAULTRE, CZ .
CLINICAL SCIENCE, 1995, 88 (06) :651-655
[5]   Noninvasive exploration of cardiac autonomic neuropathy - Four reliable methods for diabetes? [J].
Ducher, M ;
Thivolet, C ;
Cerutti, C ;
Laville, M ;
Gustin, MP ;
Paultre, CZ ;
Abou-Amara, S ;
Fauvel, JP .
DIABETES CARE, 1999, 22 (03) :388-393
[6]   STATISTICAL RELATIONSHIPS BETWEEN SYSTOLIC BLOOD-PRESSURE AND HEART-RATE AND THEIR FUNCTIONAL-SIGNIFICANCE IN CONSCIOUS RATS [J].
DUCHER, M ;
CERUTTI, C ;
GUSTIN, MP ;
PAULTRE, CZ .
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 1994, 32 (06) :649-655
[7]   RENAL-FUNCTION IN THE ELDERLY [J].
HADJAISSA, A ;
DUMAREST, C ;
MAIRE, P ;
POZET, N .
NEPHRON, 1990, 54 (04) :364-365
[8]   MEDINFO92 SATELLITE OPEN CONFERENCE ON ESTIMATION AND CONTROL OF PATIENT VARIABILITY FOR INDIVIDUALIZED ANTIBIOTIC-THERAPY - FOREWORD [J].
JELLIFFE, R ;
MAIRE, P ;
SCHUMITZKY, A .
INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING, 1994, 36 (1-2) :R11-R12
[9]  
Jelliffe R W, 1991, Proc Annu Symp Comput Appl Med Care, P922
[10]   ADAPTIVE-CONTROL OF DRUG-DOSAGE REGIMENS - BASIC FOUNDATIONS, RELEVANT ISSUES, AND CLINICAL EXAMPLES [J].
JELLIFFE, RW ;
MAIRE, P ;
SATTLER, F ;
GOMIS, P ;
TAHANI, B .
INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING, 1994, 36 (1-2) :1-23